Comparison

LL-37 vs Thymogen

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

LL-37

Also: Cathelicidin, CAP18

Clinical Trials

A naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.

ImmuneHuman Trials
Thymogen

Also: EW Dipeptide, Glu-Trp

Clinical Trials

A synthetic dipeptide (Glu-Trp) bioregulator derived from Thymalin, a thymus extract. One of Professor Khavinson's key immunomodulatory peptides, shown to stimulate T-lymphocyte development and normalize immune function. Has been used clinically in Russia for immune support.

ImmuneHuman Trials

Key Comparison Insights

  • Both peptides belong to the Immune category, suggesting similar primary applications.

Detailed Comparison

AttributeLL-37Thymogen
CategoryImmuneImmune
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionLL-37 directly kills bacteria, fungi, and some viruses by disrupting their cell membranes. It also modulates the immune response, promotes wound healing, reduces inflammation, and has anti-biofilm activity against bacterial infections.Thymogen (alpha-glutamyl-tryptophan) stimulates cellular factors of immunogenesis, promotes proliferation and differentiation of T-lymphocyte precursors into mature immunocompetent cells. It normalizes the ratio of T-helpers to T-suppressors, increases cyclic adenosine monophosphate (cAMP) in T-lymphocyte precursors, and modulates immune cell maturation. Pharmacokinetic studies show rapid tissue uptake, particularly in liver, adrenals, kidney, lymph nodes, and thymus.
Common Dosing
100-200 mcg daily
Once daily
1-2 capsules (10-20 mg) daily
1-2x daily, before meals
AdministrationSubcutaneous injection or topicalOral capsules, also available as nasal spray in some regions
Typical DurationVariable by protocol30-day courses with 2-3 month breaks
Best Time to TakeMorningMorning, before meals
Possible Side Effects
May vary by individual
  • Injection site reactions (common)
  • Skin toxicity (ulcers, burning)
  • Allergic reactions
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
  • May contribute to autoimmune conditions
  • +2 more
  • Generally well-tolerated
  • No significant side effects reported in clinical use
  • Rare allergic reactions possible
  • Individual intolerance to components
Research SummaryResearch demonstrates broad antimicrobial activity including against antibiotic-resistant bacteria. Studies show wound healing benefits, anti-biofilm effects, and immune modulation. Being investigated for chronic infections and wound healing applications.Originally isolated from Thymalin via reversed-phase HPLC, then synthesized. Clinical studies in Russia show immunomodulatory effects including normalization of T-cell subsets. Animal studies demonstrate geroprotective activity - Thymogen administration in rats led to increased survival and 1.5-fold decrease in tumor development. Has been used clinically for over 20 years as an immunomodulator.

Frequently Asked Questions: LL-37 vs Thymogen

What is the difference between LL-37 and Thymogen?

LL-37 is a immune peptide that a naturally occurring antimicrobial peptide and the only human cathelicidin. part of the innate immune system with broad-spectrum antimicrobial activity. Thymogen is a immune peptide that a synthetic dipeptide (glu-trp) bioregulator derived from thymalin, a thymus extract. one of professor khavinson's key immunomodulatory peptides, shown to stimulate t-lymphocyte development and normalize immune function. has been used clinically in russia for immune support. The main differences lie in their mechanisms of action and clinical applications.

Which is better, LL-37 or Thymogen?

Neither is universally "better" - the choice depends on your specific goals. LL-37 is typically used for immune purposes, while Thymogen is used for immune. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can LL-37 and Thymogen be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using LL-37 and Thymogen together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of LL-37 and Thymogen is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.